{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T14:13:06Z","timestamp":1790259186509,"version":"4.1.0"},"reference-count":39,"publisher":"Public Library of Science (PLoS)","issue":"5","license":[{"start":{"date-parts":[[2010,5,10]],"date-time":"2010-05-10T00:00:00Z","timestamp":1273449600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0010566","type":"journal-article","created":{"date-parts":[[2010,5,10]],"date-time":"2010-05-10T16:51:23Z","timestamp":1273510283000},"page":"e10566","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":31,"title":["Serum Anti-BPAG1 Auto-Antibody Is a Novel Marker for Human Melanoma"],"prefix":"10.1371","volume":"5","author":[{"given":"Takashi","family":"Shimbo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Tanemura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takehiko","family":"Yamazaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsuto","family":"Tamai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ichiro","family":"Katayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasufumi","family":"Kaneda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2010,5,10]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3322\/CA.2007.0010","article-title":"Cancer statistics, 2008.","volume":"58","author":"A Jemal","year":"2008","journal-title":"CA Cancer J Clin"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.cca.2005.10.029","article-title":"Novel biomarkers in malignant melanoma.","volume":"367","author":"AK Bosserhoff","year":"2006","journal-title":"Clin Chim Acta"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1093\/jnci\/djp038","article-title":"Tissue biomarkers for prognosis in cutaneous melanoma: a systematic review and meta-analysis.","volume":"101","author":"BE Gould Rothberg","year":"2009","journal-title":"J Natl Cancer Inst"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1111\/j.1600-0560.2007.00891.x","article-title":"Immunohistochemical characteristics of melanoma.","volume":"35","author":"SJ Ohsie","year":"2008","journal-title":"J Cutan Pathol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1046\/j.1365-2133.2000.03649.x","article-title":"Serological markers for melanoma.","volume":"143","author":"L Brochez","year":"2000","journal-title":"Br J Dermatol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"8079","DOI":"10.1158\/1078-0432.CCR-05-1074","article-title":"Highly sensitive detection of melanoma at an early stage based on the increased serum secreted protein acidic and rich in cysteine and glypican-3 levels.","volume":"11","author":"Y Ikuta","year":"2005","journal-title":"Clin Cancer Res"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"6612","DOI":"10.1158\/1078-0432.CCR-04-0348","article-title":"Identification of glypican-3 as a novel tumor marker for melanoma.","volume":"10","author":"T Nakatsura","year":"2004","journal-title":"Clin Cancer Res"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s12016-007-0030-y","article-title":"The pathophysiology of bullous pemphigoid.","volume":"33","author":"M Kasperkiewicz","year":"2007","journal-title":"Clin Rev Allergy Immunol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/0092-8674(95)90333-X","article-title":"Gene targeting of BPAG1: abnormalities in mechanical strength and cell migration in stratified epithelia and neurologic degeneration.","volume":"81","author":"L Guo","year":"1995","journal-title":"Cell"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.4049\/jimmunol.136.4.1231","article-title":"Molecular heterogeneity of the bullous pemphigoid antigens as detected by immunoblotting.","volume":"136","author":"RS Labib","year":"1986","journal-title":"J Immunol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/1523-1747.ep12274684","article-title":"A pool of bullous pemphigoid antigen (s) is intracellular and associated with the basal cell cytoskeleton-hemidesmosome complex.","volume":"84","author":"DF Mutasim","year":"1985","journal-title":"J Invest Dermatol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/0092-8674(81)90115-X","article-title":"Characterization of bullous pemphigoid antigen: a unique basement membrane protein of stratified squamous epithelia.","volume":"24","author":"JR Stanley","year":"1981","journal-title":"Cell"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"2480","DOI":"10.1172\/JCI116856","article-title":"A passive transfer model of the organ-specific autoimmune disease, bullous pemphigoid, using antibodies generated against the hemidesmosomal antigen, BP180.","volume":"92","author":"Z Liu","year":"1993","journal-title":"J Clin Invest"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1038\/79494","article-title":"Antibody arrays for high-throughput screening of antibody-antigen interactions.","volume":"18","author":"RMT de Wildt","year":"2000","journal-title":"Nat Biotechnol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/978-1-59745-402-5_26","article-title":"In vivo phage display selection in the human\/SCID mouse chimera model for defining synovial specific determinants.","volume":"136","author":"L Lee","year":"2007","journal-title":"Methods Mol Med"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1002\/ijc.24965","article-title":"Sterile alpha motif containing domain 9 is involved in death signaling of malignant glioma treated with inactivated Sendai virus particle (HVJ-E) or type I interferon.","volume":"126","author":"M Tanaka","year":"2010","journal-title":"Int J Cancer"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1038\/nm1496","article-title":"Humanization of autoantigen.","volume":"13","author":"W Nishie","year":"2007","journal-title":"Nat Med"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"6682","DOI":"10.1074\/jbc.M109209200","article-title":"Novel alternative splicings of BPAG1 (bullous pemphigoid antigen 1) including the domain structure closely related to MACF (microtubule actin cross-linking factor).","volume":"277","author":"M Okumura","year":"2002","journal-title":"J Biol Chem"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"11810","DOI":"10.1073\/pnas.92.25.11810","article-title":"Human neoplasms elicit multiple specific immune responses in the autologous host.","volume":"92","author":"U Sahin","year":"1995","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s00262-003-0471-y","article-title":"Identification of tumour antigens by serological analysis of cDNA expression cloning.","volume":"53","author":"G Li","year":"2004","journal-title":"Cancer Immunol Immunother"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.canlet.2007.01.002","article-title":"High throughput proteomic strategies for identifying tumour-associated antigens.","volume":"249","author":"CG Gunawardana","year":"2007","journal-title":"Cancer Lett"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.jim.2009.06.002","article-title":"Phage-display selection on tumor histological specimens with laser capture microdissection.","volume":"347","author":"Y Sun","year":"2009","journal-title":"J Immunol Methods"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"7724","DOI":"10.1158\/0008-5472.CAN-05-4441","article-title":"Selection of tumor-binding ligands in cancer patients with phage display libraries.","volume":"66","author":"DN Krag","year":"2006","journal-title":"Cancer Res"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/BF02786397","article-title":"Human tumor antigens recognized by T-cells.","volume":"16","author":"Y Kawakami","year":"1997","journal-title":"Immunol Res"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1038\/nm1100","article-title":"Cancer immunotherapy: moving beyond current vaccines.","volume":"10","author":"SA Rosenberg","year":"2004","journal-title":"Nat Med"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1046\/j.1523-1747.1998.00354.x","article-title":"Antibody responses to melanoma\/melanocyte autoantigens in melanoma patients.","volume":"111","author":"SK Huang","year":"1998","journal-title":"J Invest Dermatol"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"e5199","DOI":"10.1371\/journal.pone.0005199","article-title":"Proteome serological determination of tumor-associated antigens in melanoma.","volume":"4","author":"M Forgber","year":"2009","journal-title":"PLoS One"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1002\/ijc.11537","article-title":"Humoral immune response against melanoma antigens induced by vaccination with cytokine gene-modified autologous tumor cells.","volume":"108","author":"H Ehlken","year":"2004","journal-title":"Int J Cancer"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/ng0795-301","article-title":"The mouse dystonia musculorum gene is a neural isoform of bullous pemphigoid antigen 1.","volume":"10","author":"A Brown","year":"1995","journal-title":"Nat Genet"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1002\/cm.20235","article-title":"Dystonin\/Bpag1-A link to what?","volume":"64","author":"KG Young","year":"2007","journal-title":"Cell Motil Cytoskeleton"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1046\/j.1365-2133.2000.03838.x","article-title":"An extract of cultured A431 cells contains major tissue antigens of autoimmune bullous diseases.","volume":"143","author":"CW Lee","year":"2000","journal-title":"Br J Dermatol"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"5278","DOI":"10.1158\/0008-5472.CAN-05-4610","article-title":"Progression-specific genes identified by expression profiling of matched ductal carcinomas in situ and invasive breast tumors, combining laser capture microdissection and oligonucleotide microarray analysis.","volume":"66","author":"CS Schuetz","year":"2006","journal-title":"Cancer Res"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1196\/annals.1423.043","article-title":"Harnessing Autoimmunity (Vitiligo) to Treat Melanoma: A Myth or Reality?","volume":"1110","author":"M Ram","year":"2007","journal-title":"Ann N Y Acad Sci"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/0738-081X(89)90063-1","article-title":"Serum antibodies in vitiligo patients.","volume":"7","author":"JC Bystryn","year":"1989","journal-title":"Clin Dermatol"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.autrev.2006.03.012","article-title":"Therapeutic implications of autoimmune vitiligo T cells.","volume":"5","author":"K Oyarbide-Valencia","year":"2006","journal-title":"Autoimmun Rev"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJMoa053007","article-title":"Prognostic significance of autoimmunity during treatment of melanoma with interferon.","volume":"354","author":"H Gogas","year":"2006","journal-title":"N Engl J Med"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1111\/j.1365-2567.2006.02430.x","article-title":"Cancer immunosuppression and autoimmune disease: beyond immunosuppressive networks for tumour immunity.","volume":"119","author":"R Kim","year":"2006","journal-title":"Immunology"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1084\/jem.20050940","article-title":"Treatment of advanced tumors with agonistic anti-GITR mAb and its effects on tumor-infiltrating Foxp3+CD25+CD4+ regulatory T cells.","volume":"202","author":"K Ko","year":"2005","journal-title":"J Exp Med"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"8471","DOI":"10.1158\/0008-5472.CAN-05-0934","article-title":"Concurrent induction of antitumor immunity and autoimmune thyroiditis in CD4+ CD25+ regulatory T cell-depleted mice.","volume":"65","author":"WZ Wei","year":"2005","journal-title":"Cancer Res"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0010566","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,31]],"date-time":"2023-05-31T23:31:26Z","timestamp":1685575886000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0010566"}},"subtitle":[],"editor":[{"given":"Vladimir","family":"Brusic","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2010,5,10]]},"references-count":39,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2010,5,10]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0010566","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.4242971.4039071","asserted-by":"object"},{"id-type":"doi","id":"10.3410\/f.4242971.4385054","asserted-by":"object"}]},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,5,10]]}}}